Cognitive Functioning and Psychological Well-being in Breast Cancer Patients on Endocrine Therapy
Conclusion: No cognitive impairment was found during the two years of ET. Baseline cognitive scores and QOL dimensions proved good predictors of later anxiety and depression.
Source: In Vivo - Category: Research Authors: BIRO, E., KAHAN, Z., KALMAN, J., RUSZ, O., PAKASKI, M., IRINYI, T., KELEMEN, G., DUDAS, R., DROTOS, G., HAMVAI, C. Tags: Clinical Studies Source Type: research
More News: Anxiety | Breast Cancer | Cancer | Cancer & Oncology | Cancer Therapy | Depression | Endocrine Therapy | Psychology | Research | Study | Tamoxifen